Citius Oncology CTOR
NASDAQ CTOR
$1.01 -0.04 (-3.81%)
At close: Sep 30, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Gross Profit (2025 - 2026)

Updated

Citius Oncology's Gross Profit was $1 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.1% from the prior quarter.

Analysis

Citius Oncology (CTOR) Gross Profit (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Citius Oncology 106.82 Mn 106.82 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 1.34 Mn
Dec 31, 2025 3.15 Mn
API Access

Citius Oncology Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CTOR&period=max&api_key=YOUR_API_KEY